Pioneers in Tissue Engineering

co.don AG is one of the leading specialists worldwide in cell cultivation for the regenerative treatment of articular cartilage defects.

In many cases the use of the company's patented pharmaceutical product can avert or delay the need for joint replacement surgery. Orthopaedic and traumatologic surgeons are increasingly applying these regenerative therapy methods.

co.don AG is listed on the Frankfurt Stock Exchange (ISIN: DE000A1K0227).